Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer

Gastric Cancer

Volumn 15, Issue 4, 2012, Pages 440-450

  Jiang, Yang ^a   He, Yan ^a   Li, Hui ^a   Li, Hui Ning ^a   Zhang, Lei ^a   Hu, Wei ^a   Sun, Ya Meng ^a   Chen, Fu Lai ^a   Jin, Xiao Ming ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell marker; Differentiation; Gastric cancer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BREAST CANCER RESISTANCE PROTEIN; CANCER STEM CELL MARKER; CD133 ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CELL MEMBRANE; CELL PROLIFERATION; CELL STRUCTURE; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CANCER; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; P-GLYCOPROTEIN; PEPTIDES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84870366361     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0140-y     Document Type: Article

References (20)

1. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23: 7274-82.
2. Ricci-Vitiani L, Pagliuca A, Palio E, Zeuner A, De Maria R. Colon cancer stem cells. Gut. 2008;57: 538-48.
3. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3: 730-7.
4. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres- Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367: 645-8.
5. Natarajan TG, FitzGerald KT. Markers in normal and cancer stem cells. Cancer Biomark. 2007;3: 211-31.
6. Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med. 2007;11: 981-1011.
7. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd Ed. Gastric Cancer. 1998; 1: 10-24.
8. He Y, Jiang Y, Li YJ, Liu XH, Zhang L, Liu LJ, et al. 19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo. J Gastroenterol Hepatol. 2010;25: 935-41.
9. Surowiak P, Materna V, Matkowski R, Szczuraszek K, Kornafel J, Wojnar A, et al. Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance. Breast Cancer Res. 2005;7:R862-70.
10. Lazar D, Taban S, Sporea I, Dema A, Cornianu M, Lazar E, et al. Gastric cancer: correlation between clinicopathological factors and survival of patients. II. Rom J Morphol Embryol. 2009;50: 185-94.
11. Kesler KA, Rieger KM, Ganjoo KN, Sharma M, Fineberg NS, Einhorn LH, et al. Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery. J Thorac Cardiovasc Surg. 1999;118: 692-700.
12. Rizo A, Vellenga E, de Haan G, Schuringa JJ. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? Hum Mol Genet. 2006;2:R210-9.
13. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2? and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 2005;65: 6207-19.
14. List AF, Kopecky KJ, Willman CL, Head DR, Persons DL, Slovak ML, et al. Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. Blood. 2001;98: 3212-20.
15. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell. 2009;4: 226-35.
16. Zen Y, Fujii T, Yoshikawa S, Takamura H, Tani T, Ohta T, et al. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol. 2007;170: 1750-62.
17. Shmelkov SV, St Clair R, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol. 2005;37: 715-9.
18. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432: 396-401.
19. Beier D, Wischhusen J, Dietmaier W, Hau P, Proescholdt M, Brawanski A, et al. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol. 2008;18: 370-7.
20. Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM, Held- Feindt J. Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol. 2008;86: 31-45.